AptarGroup (ATR) Stock: Buy, Sell, or Hold?
ATR - AptarGroup, Inc.
$125.63
-0.14 (-0.11%)
▼
5d:
+4.46%
30d:
+0.14%
90d:
-2.61%
HOLD
MODERATE Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Oct 29, 2026
6d
Get Alerted When ATR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ATR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ATR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$187.94
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$116.69
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ATR is currently trading at $125.63, which is considered extended relative to its 30-day fair value range of $120.72 to $125.10. The stock's valuation (Forward PE: 20.3) is in line with its historical norms (20.5). Remarkably, the market is currently pricing in an annual earnings decline of 0.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ATR is showing sideways momentum. The price is approaching resistance at $126.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $161.44 (+28.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ATR is showing sideways momentum. The price is approaching resistance at $126.53. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $161.44 (+28.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$120.72 -
$125.10
Company Quality Score
66/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
60.4%
Protect Your Profits
Holding ATR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (59/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 28.5% below Wall St target ($161.44)
- NEUTRAL: Bottoming setup forming (59/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$120.72 -
$125.10
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$5.10
(4.1%)
Support & Resistance Levels
Support Level
$118.34
Resistance Level
$126.54
Current Trend
Sideways
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.33
Wall Street Target
$161.44
(+28.5%)
Revenue Growth (YoY)
6.3%
Earnings Growth (YoY)
-18.6%
Profit Margin
9.2%
Valuation Discount vs History
-0.3% cheaper
PE vs Historical
20.3 vs 20.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.3%
(market-implied from PE analysis)
1-Year Target
$125.25
(0%)
2-Year Target
$124.88
(-1%)
3-Year Target
$124.50
(-1%)
3-Yr Target (if PE normalizes)
(PE: 20→21)
$125.54
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.3, Growth: 12.5%)
$178.95
(+42%)
Base:
(SPY PE: 19.9, Growth: 12.5%)
$174.81
(+39%)
Bear:
(PE: 16.9, Growth: 12.5%)
$148.59
(+18%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (23x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 22.70 | Current EPS (TTM): $5.54
Bull Case
$154.32
(+23%)
Analyst growth 11.5%, PE expands to 25.0
Base Case
$140.29
(+12%)
Market implied 11.5%, PE stable at 22.7
Bear Case
$85.52
(-32%)
Severe decline -20.0%, PE contracts to 19.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.3 to 20.5
Stabilization Target:
$126.68
(+0.8%)
PE Expansion Potential:
+0.8%
Share & Embed Analysis
Last updated: October 22, 2026 7:04 AM ET
Data refreshes hourly during market hours. Next update: 8:04 AM
Data refreshes hourly during market hours. Next update: 8:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$479 | 41 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$83 | 45 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
22 analysts |
$198 | 53 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
17 analysts |
$413 | 37 SELL |
|
STVN
Stevanato Group SpA |
BUY
14 analysts |
$24 | 67 BUY |
Advanced ATR Option Strategies
Professional options setups generated by AI based on today's ATR price and gamma walls.
